Lily Chu

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: iacfsme.org

Lily Chu, MD, MSHS, is board certified in both internal medicine and geriatric medicine.[1]

Education[edit | edit source]

  • Geriatric Medicine Fellowship, University of California, Los Angeles
  • MSHS, Public Health, University of California, Los Angeles
  • Internal Medicine Residency, University of Rochester
  • MD, University of Washington
  • BS, Biology, University of Washington[2]

Boards and Committees[edit | edit source]

ME/CFS Common Data Element (CDE) Project[edit | edit source]

Dr Chu is Co-chair of Post-exertional Malaise Working Group and a member of the Sleep Working Group and the Biomarkers Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Elements (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[6]

Quotes[edit | edit source]

  • 2016, "Ultimately the best way to prevent suicide in ME/CFS will be to find effective disease-modifying treatments or cures for it."[7]

Publications[edit | edit source]

Open Letter to The Lancet[edit | edit source]

Three open letters to the editor of The Lancet have been sent urging the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Chu, along with 41 colleagues in the ME/CFS field, signed the second letter.

Notable studies[edit | edit source]

  • 2017, Cytokine signature associated with disease severity in chronic fatigue syndrome patients[11](Full Text)
  • 2017, Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria[12]
  • 2019, Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome[14](Full text)

Talks and interviews[edit | edit source]

Written questions and answers to Dr. Chu's webinar

HHS/CFSAC Testimony[edit | edit source]

Online presence[edit | edit source]

  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Website

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. "Lily Chu". Retrieved Feb 7, 2019. 
  2. "Lily Chu". LinkedIn. Retrieved Feb 7, 2019. 
  3. Stanford ME/CFS Initiative. "Meet the Team". ME/CFS Initiative. Retrieved Feb 7, 2019. 
  4. International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. "Leadership of the IACFS". Retrieved Feb 7, 2019. 
  5. http://me-pedia.org/wiki/Institute_of_Medicine_report
  6. "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved Oct 11, 2019. 
  7. http://http://iacfsme.org/PDFS/2016MayNesletter/Attachment-03-Dr-Lily-Chu-ME-CFS-and-suicide.aspx
  8. Chu, Lily; Friedberg, Fred; Friedman, Kenneth J.; Littrell, Nereida; Stevens, Staci; Vallings, Ros (2012). "Exercise and chronic fatigue syndrome: maximize function, minimize post-exertional malaise". European Journal of Clinical Investigation. 42 (12): 1362–1362. doi:10.1111/j.1365-2362.2012.02723.x. ISSN 1365-2362. 
  9. Chu, Lily; Valencia, Ian J.; Montoya, Jose G. (2017). "Differences of opinion on systemic exercise intolerance disease are not 'mistakes': a rejoinder to Jason Sunnquist, Gleason and Fox". Fatigue: Biomedicine, Health & Behavior. doi:10.1080/21641846.2017.1362750. 
  10. Stringer, EA; Baker, KS; Carrol, IR; Montoya, JG; Chu, L; Maeker, HT; Younger, JW (Apr 9, 2013). "Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology,". J Transl Med. doi:10.1186/1479-5876-11-93. PMID 23570606. 
  11. Montoya, Jose G.; Holmes, Tyson H.; Anderson, Jill N.; Maecker, Holden T.; Rosenberg-Hasson, Yael; Valencia, Ian J.; Chu, Lily; Younger, Jarred W.; Tato, Cristina M.; Davis, Mark M. (2017). "Cytokine signature associated with disease severity in chronic fatigue syndrome patients". Proceedings of the National Academy of Sciences of the United States of America. 114 (34): E7150-E7158. doi:10.1073/pnas.1710519114. 
  12. Chu, Lily; Norris, Jane; Valencia, Ian J.; Montoya, Jose G. (2017). "Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria". Fatigue: Biomedicine, Health & Behavior. 5. doi:10.1080/21641846.2017.1299079. 
  13. Chu, Lily; Valencia, Ian J.; Garvert, Donn W.; Montoya, Jose G. (Jun 1, 2018). "Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey". PLOS One. doi:10.1371/journal.pone.0197811. 
  14. Chu, Lily; Valencia, Ian J.; Garvert, Donn W.; Montoya, Jose G. (Feb 5, 2019). "Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Pediatrics. 7 (12). doi:10.3389/fped.2019.00012. 

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Systemic exertion intolerance disease (SEID) - A term for ME/CFS that aims to avoid the stigma associated with the term "chronic fatigue syndrome", while emphasizing the defining characteristic of post-exertional malaise (PEM). SEID was defined as part of the diagnostic criteria put together by the Institute of Medicine (IOM) report of 10 February 2015.

Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Chronic fatigue syndrome advisory committee (CFSAC) - (sometimes pronounced SIF-SACK) A US government advisory council that met twice per year, covering current topics related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Meetings usually lasted for two days and the results were presented to the Secretary of Health and Human Services (HHS). After 15 years, on September 5, 2018, CFSAC's charter was not renewed by the Department of HHS, effectively dissolving the committee without notice or warning.

Post-exertional malaise (PEM) - A notable exacerbation of symptoms brought on by small physical or cognitive exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.